PaxMedica, Inc.(MX:PXMD)
MX:PXMD
PaxMedica, Inc. financials statements
PaxMedica, Inc. (PXMD) Ratios
0 Followers
PaxMedica, Inc. Ratios
MX:PXMD's free cash flow for Q2 2024 was $-1.30M. For the 2024 fiscal year, MX:PXMD's free cash flow was increased by $0.00 and operating cash flow was $-1.30M. See a summary of the company’s cash flow.
| Ratios | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.16 | 1.05 | 0.04 | 0.20 | 0.20 |
| Quick Ratio | 3.16 | 1.05 | 0.04 | 0.20 | 0.20 |
| Cash Ratio | 2.62 | 0.91 | 0.04 | 0.20 | 0.20 |
| Solvency Ratio | -7.04 | -7.06 | -1.20 | -1.48 | -4.86 |
| Operating Cash Flow Ratio | -6.00 | -2.90 | -0.51 | -0.41 | -3.40 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -34.98 | 0.00 | -3.84 | 0.00 |
| Net Current Asset Value | $ 3.39M | $ 108.80K | $ -10.31M | $ -4.63M | $ -98.30K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.08 | 0.00 | 0.54 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 1.60 | 0.00 | -0.13 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.61 | 0.00 | -0.15 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.68 | 20.26 | -0.06 | -0.24 | -0.25 |
| Debt Service Coverage Ratio | -1761.59 | -115.78 | -3.57 | -5.14 | 0.00 |
| Interest Coverage Ratio | -1761.59 | -2024.82 | -2.57 | -9.13 | 0.00 |
| Debt to Market Cap | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.35 | 4.05 | 2.07 | 0.00 |
| Net Debt to EBITDA | 0.29 | 0.10 | 0.06 | 0.09 | 0.04 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 127.43% | 108.47% | 100.00% |
| EBT Per EBIT | 113.29% | 139.59% | 142.11% | 140.60% | 100.00% |
| Return on Assets (ROA) | -321.98% | -671.50% | -2008.89% | -755.50% | -2401.09% |
| Return on Equity (ROE) | -540.31% | -13604.78% | 128.95% | 183.41% | 609.35% |
| Return on Capital Employed (ROCE) | -415.56% | -9746.32% | 71.20% | 120.25% | 609.35% |
| Return on Invested Capital (ROIC) | -415.56% | -3755.72% | 71.20% | 138.56% | 609.35% |
| Return on Tangible Assets | -321.98% | -671.50% | -2008.89% | -755.50% | -2401.09% |
| Earnings Yield | -1452.87% | -83.41% | -22.54% | -17.26% | -1.22% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -6.48 | -11.81 | -7.96 | -3.99 | -0.71 |
| Free Cash Flow Per Share | -6.48 | -11.81 | -7.96 | -3.99 | -0.71 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | -34.98 | 0.00 | -3.84 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -855.40% | -34.21% | -9.53% | -4.78% | -0.85% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.07 | -1.20 | -4.44 | -5.79 | -82.10 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.37 | 163.10 | -5.72 | -10.63 | -500.30 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.12 | -2.92 | -10.49 | -20.94 | -117.27 |
| Price-to-Operating Cash Flow Ratio | -0.12 | -2.92 | -10.49 | -20.94 | -117.27 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.02 | -0.11 | -0.00 | 0.00 |
| Enterprise Value Multiple | 0.21 | -0.97 | -7.97 | -8.66 | -82.06 |
| Enterprise Value | -3.45M | 16.02M | 57.39M | 48.67M | 49.16M |
| EV to EBITDA | 0.21 | -0.97 | -7.97 | -8.66 | -82.06 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | 0.32 | -2.64 | -10.41 | -20.72 | -117.21 |
| EV to Operating Cash Flow | 0.32 | -2.64 | -10.41 | -20.72 | -117.21 |
| Tangible Book Value Per Share | 2.04 | 0.21 | -14.59 | -7.86 | -0.17 |
| Shareholders’ Equity Per Share | 2.04 | 0.21 | -14.59 | -7.86 | -0.17 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.28 | -0.27 | -0.08 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -11.00 | -28.79 | -18.81 | -14.41 | -1.02 |
| Tax Burden | 1.00 | 1.00 | 1.27 | 1.08 | 1.00 |
| Interest Burden | 1.00 | 1.03 | 1.38 | 1.08 | 0.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.59 | 0.41 | 0.54 | 0.30 | 0.70 |
Currency in USD
